These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31560040)

  • 1. Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.
    Chiba M; Nakane K; Abe H; Komatsu M; Tozawa H
    Inflamm Bowel Dis; 2019 Oct; 25(11):e146-e147. PubMed ID: 31560040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
    Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Carr RM; Patel A; Bownik H; Oranu A; Kerner C; Praestgaard A; Forde KA; Reddy KR; Lichtenstein GR
    Dig Dis Sci; 2017 May; 62(5):1354-1361. PubMed ID: 28265826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of Ulcerative Colitis during a Low-Carbohydrate Weight-Loss Diet and Treatment with a Plant-Based Diet: A Case Report.
    Chiba M; Tsuda S; Komatsu M; Tozawa H; Takayama Y
    Perm J; 2016; 20(1):80-4. PubMed ID: 26824967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Chicco F; Magrì S; Cingolani A; Paduano D; Pesenti M; Zara F; Tumbarello F; Urru E; Melis A; Casula L; Fantini MC; Usai P
    Inflamm Bowel Dis; 2021 Jan; 27(1):1-9. PubMed ID: 32440680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.
    Kodali A; Okoye C; Klein D; Mohamoud I; Olanisa OO; Parab P; Chaudhary P; Mukhtar S; Moradi A; Hamid P
    Cureus; 2023 Aug; 15(8):e42995. PubMed ID: 37671212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B
    J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
    Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
    World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse Prevention by Plant-Based Diet Incorporated into Induction Therapy for Ulcerative Colitis: A Single-Group Trial.
    Chiba M; Nakane K; Tsuji T; Tsuda S; Ishii H; Ohno H; Watanabe K; Obara Y; Komatsu M; Sugawara T
    Perm J; 2019; 23():. PubMed ID: 31050638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of non-alcoholic fatty liver disease in patients with Crohn's disease but not ulcerative colitis.
    Li D; Lu C; Yu C
    Int J Clin Exp Pathol; 2017; 10(10):10633-10639. PubMed ID: 31966406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Noorian S; Jeon Y; Nguyen MT; Sauk J; Limketkai BN
    Inflamm Bowel Dis; 2022 Jun; 28(6):878-887. PubMed ID: 34374782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Principi M; Iannone A; Losurdo G; Mangia M; Shahini E; Albano F; Rizzi SF; La Fortezza RF; Lovero R; Contaldo A; Barone M; Leandro G; Ierardi E; Di Leo A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1589-1596. PubMed ID: 29688336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advancement in inflammatory bowel disease by incorporating plant-based diet.
    Chiba M; Tsuji T; Komatsu M
    Transl Gastroenterol Hepatol; 2023; 8():38. PubMed ID: 38021365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of increased physical activity without body weight loss on hepatic inflammation in patients with nonalcoholic fatty liver disease.
    Asada F; Nomura T; Hosui A; Kubota M
    Environ Health Prev Med; 2020 Jun; 25(1):18. PubMed ID: 32522147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.